Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 15201 - 15225 of 15459 in total
Investigational
Investigational
Investigational
AMG-553 is an adoptive, anti-FLT3 chimeric antigen receptor T-cell therapy generated through transduction of autologous T-cells with a self-inactivating human immunodeficiency virus-1 based lentiviral vector.
Investigational
Hu-PHEC Liver is an adult hemogenic endothelial cells.
Investigational
TCB-008 is an Allogeneic CD3+ T lymphocyte ex vivo expanded expressing the gamma delta T-cell receptor.
Investigational
Investigational
Investigational
NNC0114-0006 is an anti-interleukin 21 monoclonal antibody
Investigational
SMART101 is an investigational cell therapy comprising human allogeneic CD34-CD7+ T cell progenitors that were cultured ex vivo.
Investigational
E59 is a humanized IgG1 low affinity allergic reactivity inhibiting (LARI) monoclonal antibody. It was developed by Sixal Inc.
Investigational
Investigational
SGN-B6A is a humanized immunoglobulin G1 anti-integrin beta-6 monoclonal antibody conjugated to monomethyl auristatin E.
Investigational
IFx-Hu2.0 is an investigational cancer vaccine. It is composed of plasmid DNA encoding the streptococcal membrane protein, Emm55, contained within a cationic polymer.
Investigational
CAM-101 is an allogeneic human platelet lysate product depleted of fibrinogen.
Investigational
FLT201 is a recombinant adeno-associated viral vector serotype S3 containing codon optimised expression cassette encoding human beta (β)-glucocerebrosidase variant 85 (GCasevar85)
Investigational
tgAAG-76 consists of a recombinant adeno-associated virus (serotype 2) (rAAV2) gene transfer agent expressing RPE65.
Investigational
RBIO-101 is a recombinant adeno-associated virus vector encoding human CYP4V2 protein.
Investigational
AGTC-401 is a recombinant adeno-associated virus vector expressing the cyclic nucleotide gated channel beta subunit (rAAV-CNGB3).
Investigational
Investigational
RO7200220 is a recombinant fully humanized anti-IL 6 monoclonal antibody.
Investigational
RAPA-201 is an autologous rapamycin-resistant T-cell therapy.
Investigational
PB-722 is a long-acting glucagon receptor agonist.
Investigational
AVID-200 is an Anti-transforming growth factor beta (TGF-β) trap fusion protein.
Investigational
Investigational
Displaying drugs 15201 - 15225 of 15459 in total